Clinical epidemiology and risk factors for community-onset isolation of extended-spectrum β-lactamase-producing Escherichia coli from clinical specimens in Japan
Clinical epidemiology and risk factors for community-onset isolation of extended-spectrum β-lactamase-producing Escherichia coli from clinical specimens in Japan. // Journal of Infection and Chemotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1341321X26001571?dgcid=rss_sd_all
Clinical epidemiology and risk factors for community-onset isolation of extended-spectrum β-lactamase-producing Escherichia coli from clinical specimens in Japan. Journal of Infection and Chemotherapy. https://www.sciencedirect.com/science/article/pii/S1341321X26001571?dgcid=rss_sd_all
“Clinical epidemiology and risk factors for community-onset isolation of extended-spectrum β-lactamase-producing Escherichia coli from clinical specimens in Japan.” Journal of Infection and Chemotherapy.
@article{article100681,
title = {Clinical epidemiology and risk factors for community-onset isolation of extended-spectrum β-lactamase-producing Escherichia coli from clinical specimens in Japan},
journal = {Journal of Infection and Chemotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1341321X26001571?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...